# Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients

> **NCT00932256** · PHASE1 · COMPLETED · sponsor: **Magna Pharmaceuticals, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** STAHIST NDC #58407-536-01

## Key facts

- **NCT ID:** NCT00932256
- **Lead sponsor:** Magna Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-10
- **Final completion:** 2010-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2010-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00932256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00932256, "Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00932256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*